MABS434

Anti-PCSK9 Antibody, clone 9B3.1

culture supernatant, clone 9B3.1, from mouse

• 别名: Proprotein convertase subtilisin/kexin type 9, NARC-1, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, Subtilisin/kexin-like protease PC9
• 分類程式碼代碼: 12352203
• eCl@ss: 32160702

属性

• 生物源: mouse
• 品質等級: 100
• 抗體表格: culture supernatant
• 抗體產品種類: primary antibodies
• 無性繁殖: 9B3.1, monoclonal
• 物種活性: human
• 技術: immunohistochemistry: suitable (paraffin); western blot: suitable
• 同型: IgG2aκ
• NCBI登錄號: NP_777596
• UniProt登錄號: Q8NBP7
• 運輸包裝: ambient
• 目標翻譯後修改: unmodified
• 基因資訊: human ... PCSK9(255738)

说明

一般說明

Proprotein convertase subtilisin/kexin type 9 (UniProt Q8NBP7; also known as NARC-1, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, Subtilisin/kexin-like protease PC9) is encoded by the PCSK9 (also known as HCHOLA3, LDLCQ1, NARC1, PSEC0052) gene (Gene ID 255738) in human. PCSK9 is a proprotein convertase expressed in the hepatocyte and to a lesser extent also in the intestine and kidney. PCSK9 is produced as a precusor protein with a signal peptide (a.a.1-30) and a propeptide sequence (a.a. 31-152) that undergo posttranslational autocleavage to yield the mature PCSK9 protein (a.a. 153-692). PCSK9 utilizes its proteolytic activity only in autocleavage during protein maturation, a process that is necessary for its secretion. Once secreted into the plasma, PCSK9 binds LDL receptor (LDL-R), causing LDL-R endocytosis and lysosomal degradation, effectively reducing cell surface LDL-R population. Both PCSK9 and LDL-R are transcribed by sterol-responsive element-binding protein 2 (SREBP2) in response to lowered cellular cholesterol level, allowing enhanced, but not unfettered cellular cholesterol uptake by LDL-R. PCSK9 also binds very low density lipoprotein (VLDL) receptor and apolipoprotein E receptor 2, and thereby interferes with uptake of circulating VLDL particles and apolipoproteins.

特異性

Clone 9B3.1 detects the precursor and mature forms of human PCSK9 (NARC-1) by targeting an epitope within the N-terminal region of the mature sequence.

免疫原

GST-tagged recombinant human mature NARC-1 (PCSK9) N-terminal fragment.

應用

Detect PCSK9 using this mouse monoclonal Anti-PCSK9, clone 9B3.1 Antibody, Cat. No. MABS434, validated for use in Immunohistochemistry (Paraffin) and Western Blotting.

Immunohistochemistry Analysis: A 1:50 dilution from a representative lot detected NARC-1 (PCSK9) in human colon cancer, normal kidney and prostate tissue sections.

Western Blotting Analysis: A 1:500 dilution from a representative lot detected NARC-1 (PCSK9) in 10 µg of human colon tumor tissue lysate.

Research Category
Signaling

品質

Evaluated by Western Blotting in SW480 cell lysate.

Western Blotting Analysis: A 1:500 dilution of this hybridoma culture supernatant detected NARC-1 (PCSK9) in 10 µg of SW480 human colon adenocarcinoma cell lysate.

標靶描述

~75/60 kDa observed. 74.29 kDa (prepro-form; a.a. 1-692), 71.05 kDa (pro-form; a.a. 31-692), and 57.29 kDa (mature form; a.a. 153-692) calculated. Uncharacterized bands may be observed in some lysate(s).

外觀

Unpurified

Mouse IgG2a hybridoma culture supernatant without azide.

儲存和穩定性

Stable for 1 year at -20°C from date of receipt.

Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

其他說明

Concentration: Please refer to lot specific datasheet.

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全信息

• 儲存類別代碼: 10 - Combustible liquids
• 水污染物質分類（WGK）: WGK 2